Mach7 Technologies Ltd (ASX: M7T) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Mach7 Technologies Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $231.77 million
P/E Ratio 1,428.57
Dividend Yield N/A
Shares Outstanding 236.50 million
Earnings per share -0.034
Dividend per share N/A
Year To Date Return -19.60%
Earnings Yield 0.07%
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of May 24th 2021

Mach7 Technologies Ltd (ASX: M7T)
Latest News

M7T ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Mach7 Technologies Ltd

Mach7 Technologies Ltd is engaged in enterprise imaging data sharing, storage, and interoperability for healthcare enterprises globally. The company's operating segment includes Software licenses and Professional services. It generates maximum revenue from the Software licenses segment. Geographically, it derives a majority of revenue from the United States and also has a presence in the Middle East; Asia/Pacific and Europe, and other regions. The company's solutions includeManagement Studio; Diagnostic Studio; and Clinical Studio.

M7T Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
27 Jul 2021 $0.99 $-0.01 -1.00% 771,879 $1.01 $1.01 $0.98
26 Jul 2021 $1.01 $0.00 0.00% 272,332 $1.00 $1.02 $0.99
23 Jul 2021 $1.00 $0.00 0.00% 403,845 $1.01 $1.01 $0.98
22 Jul 2021 $1.01 $0.03 3.09% 870,193 $0.97 $1.01 $0.97
21 Jul 2021 $0.97 $0.07 7.73% 1,404,221 $0.90 $0.98 $0.89
20 Jul 2021 $0.91 $-0.05 -5.21% 3,696,934 $0.97 $0.97 $0.88
19 Jul 2021 $0.96 $-0.02 -2.05% 2,824,614 $0.98 $1.01 $0.96
16 Jul 2021 $0.98 $-0.02 -2.02% 860,454 $0.99 $0.99 $0.96
15 Jul 2021 $0.99 $-0.01 -1.00% 376,796 $1.00 $1.00 $0.98
14 Jul 2021 $1.00 $-0.02 -1.96% 547,977 $1.02 $1.03 $1.00
13 Jul 2021 $1.02 $-0.01 -0.97% 337,935 $1.03 $1.05 $1.01
12 Jul 2021 $1.03 $0.01 0.98% 258,313 $1.05 $1.05 $1.01
09 Jul 2021 $1.03 $-0.02 -1.92% 250,562 $1.04 $1.04 $1.02
08 Jul 2021 $1.04 $-0.01 -0.95% 417,612 $1.05 $1.05 $1.04
07 Jul 2021 $1.05 $0.06 6.06% 321,201 $1.00 $1.05 $1.00
06 Jul 2021 $0.99 $-0.01 -1.00% 547,398 $1.00 $1.02 $0.99
05 Jul 2021 $1.00 $-0.05 -4.74% 510,475 $1.06 $1.06 $1.00
02 Jul 2021 $1.06 $-0.02 -1.87% 206,205 $1.07 $1.08 $1.05
01 Jul 2021 $1.07 $0.01 0.94% 573,534 $1.08 $1.08 $1.07
30 Jun 2021 $1.07 $0.00 0.00% 569,930 $1.09 $1.09 $1.06
29 Jun 2021 $1.07 $0.01 0.95% 533,627 $1.05 $1.09 $1.04

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
11 May 2021 David Chambers Buy 37 $38,828
On-market trade. As per announcement on 14/05/2021.
30 Apr 2021 Mike Lampron Buy 116 $20,416
Exercise of options.
30 Apr 2021 Mike Lampron Sell 116 $140,744
On-market trade.
30 Apr 2021 Mike Lampron Exercise 116 $20,416
Exercise of options.
03 Dec 2020 Mike Lampron Issued 378 $495,329
Issue of securities. 378,114 - Performance Rights
03 Dec 2020 Robert Bazzani Issued 25 $32,750
Issue of securities.
03 Dec 2020 Eliot Siegel Issued 25 $32,750
Issue of securities.
03 Dec 2020 David Chambers Issued 35 $45,850
Issue of securities.
02 Dec 2020 Eliot Siegel Issued 21 $27,957
Issue of securities.
02 Dec 2020 David Chambers Issued 30 $40,386
Issue of securities.
02 Dec 2020 Robert Bazzani Issued 21 $27,957
Issue of securities.
25 Sep 2020 Mike Lampron Buy 1 $1,199
On-market trade.
22 Sep 2020 David Chambers Buy 10 $10,000
On-market trade.
22 Sep 2020 Robert Bazzani Buy 25 $24,600
On-market trade.
08 Sep 2020 Mike Lampron Buy 55 $55,880
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr David Chambers Non-Executive DirectorNon-Executive Chairman Aug 2018
Mr Chambers has more than 30 years experience in the Healthcare and Life Science industry and a track record in healthcare IT systems through a series of executive roles in Australia, North America, Europe, and Asia. He recently acted as Managing Director, Asia-Pacific, of Allscripts Healthcare Solutions until 30th June 2020. Prior to that he was General Manager, Asia and ANZ with Carestream Health. He also served eleven years with Agfa Healthcare, including managing their Informatics group in Asia Pacific, and culminating in his elevation to Vice President of Agfa North America. Mr Chambers is a member of the Risk Management Committee.
Ms Jennifer (Jenni) Pilcher Chief Financial OfficerCompany Secretary May 2018
--
Dr Eliot L Siegel Non-Executive Director Aug 2018
Dr Siegel is a leader in the world of radiology and imaging informatics and artificial intelligence applications in medicine. He is currently Professor and Vice Chair of information systems at the University of Maryland School of Medicine, Department of Diagnostic Radiology, and the Chief of Radiology and Nuclear Medicine for the Veterans Affairs Maryland Healthcare System, both in Baltimore, MD as well as professor of computer science and biomedical engineering at the undergraduate campuses of the University of Maryland. He has written over 300 articles and book chapters about PACS (Picture Archiving and Communication Systems) and digital imaging, and has edited six books on the topic, including Filmless Radiology and Security Issues in the Digital Medical Enterprise. He has given more than 1,000 presentations throughout the world on a range of topics which involves the use of computers in medicine and artificial intelligence. Dr Siegel was symposium chairman for the Society of Photo-optical and Industrial Engineers (SPIE) Medical Imaging Meeting for three years and has been honoured as a fellow in that organization as well as the American College of Radiology. He is also a Board Member of Carestream Health. Dr Siegel is a member of the Risk Management Committee.
Mr Mike Lampron Chief Operating OfficerChief Executive OfficerManaging Director Mar 2019
Mr Lampron has over 20 years of experience in business and management for Healthcare IT companies. He brings a broad experience ranging from private start-up organizations as well as from companies such as IBM and GE. He was previously the Chief Executive Officer for a National Teleradiology Company and has a ability to drive results through a combination of analysis, execution and teamwork. Mr Lampron is a member of the Risk Management Committee.
Mr Robert John Bazzani Non-Executive Director Jan 2020
Mr Bazzani has had spend over 20 years with the consulting firm KPMG, where he served as Chairman of KPMG Victoria, National Managing Partner for KPMG Australia's Enterprise Division and National Managing Partner for KPMG's M&A Division. Whilst in these roles, he was a Member of KPMG's National Executive Committee (NEC), which oversees and is in charge for the firm's turnover, decision making, profitability and operations. He has played a role in advising clients (public, private, and global subsidiaries) on commercial maters, public transitions, corporate governance, M&A and has been engage with Government and Regulators. With experience in corporate advisory, he has commercial and industry knowledge across financial services, asset and wealth management, property, insurances and consumer & industrial markets. Mr Bazzani is chairman of the Risk Management Committee.
Mr Philippe Houssiau Non-Executive Director Jan 2021
Mr Houssiau has held various executive and board member roles for Healthcare IT companies across the globe. His experience includes work as a small company owner, consultancy partner, entrepreneur, CEO and chairman. Previously, Philippe has held the role of CEO for Agfa Healthcare and Alliance Healthcare. He was a partner with Hg Private Equity and Chairman of Orion Health. Philippe has also held various senior manager roles with Price Waterhouse.
Ravi Krishnan Founder Chief Strategy Officer
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Sandhurst Trustees Ltd 38,028,328 16.23%
J P Morgan Nominees Australia Pty Limited 26,700,348 11.39%
National Nominees Limited 20,624,535 8.80%
HSBC Custody Nominees (Australia) Limited 14,612,943 6.23%
UBS Nominees Pty Ltd 6,024,080 2.57%
PT Dwi Satrya Utama 4,392,959 1.87%
Perco Group Pty Ltd 4,080,000 1.74%
BPNT Pty Ltd 4,037,009 1.72%
Citicorp Nominees Pty Limited 3,904,616 1.67%
Padmalwar Prakash 3,569,921 1.52%
Mr Ravindran Krishnan 3,395,416 1.45%
Chew & Partners (Import & Export) Pte Ltd 2,900,074 1.24%
HSBC Custody Nominees (Australia) Limited GSCO ECA 2,234,580 0.95%
Albert Liong Pak Fai 2,044,189 0.87%
TY Webb Pty Ltd 1,339,444 0.57%
BNP Paribas Noms Pty Ltd <Drp> 1,324,898 0.57%
BNP Paribas Noms Pty Ltd <Uob Kay Hian Priv Ltd Drp> 1,235,314 0.53%
Australian Executor Trustees Limited 1,114,599 0.48%
Moggs Creek Pty Ltd 1,000,000 0.43%
Antonius Rudy Sugiarto 967,113 0.41%

Profile

since

Note